Скачать или смотреть Eli Lilly partners NVIDIA to build 'most powerful' supercomputer

In today’s headlines – 29 October:

Eli Lilly and NVIDIA have joined forces on an ambitious plan – building pharma's most powerful AI-powered supercomputer for drug discovery.

Emma Walmsley's last set of financial results as GSK's chief executive has gone swimmingly, allowing the company to raise its 2025 forecasts.

BridgeBio's week just went from great to superb, as it reports a second positive topline result in a pivotal trial of a late-stage pipeline drug, this time for ADH1 candidate encaleret.

CSL says flu vaccination rates in the US are expected to fall 12% to 14% this year, and have scuppered its plan to spin out its vaccines unit Seqirus.

MSD and Eisai's oncology partnership has had mixed fortunes this week, with a disappointment in liver cancer and encouraging data in kidney cancer.

Subscribe to ‪@Pharmaphorum‬ for daily news updates and check out www.pharmaphorum.com for more insights and analysis.

#news #pharma #pharmanews #pharmainnovation #pharmaindustry #lifesciences #biotechnews #biopharma #drugdevelopment #drugdiscovery #elililly #nvidia #supercomputers #gsk #bridgebio #csl #fluvaccine #msd #eisai #oncology

As an official Frontiers Health conference partner, we are pleased to offer pharmaphorum readers an exclusive 20% discount. Don’t miss this unique opportunity to engage with some of the brightest minds in modern healthcare to discuss the biggest trends, opportunities, and challenges facing today’s health innovators.

Click below and use promo code: FH25PHP20 to register at a reduced price: https://www.frontiers.health/2025-reg...